(-)-Phenserine tartrate (PhenT) as a treatment for traumatic brain injury.
CONCLUSION: In the light of its tolerability in AD clinical trials, PhenT is an agent that can be fast-tracked for evaluation in not only civilian TBI, but also as a potentially protective agent in battlefield conditions where TBI and chemical weapon exposure are increasingly jointly occurring.
PMID: 31828969 [PubMed - as supplied by publisher]
Source: CNS Neuroscience and Therapeutics - Category: Neuroscience Authors: Greig NH, Lecca D, Hsueh SC, Nogueras-Ortiz C, Kapogiannis D, Tweedie D, Glotfelty EJ, Becker RE, Chiang YH, Hoffer BJ Tags: CNS Neurosci Ther Source Type: research
More News: Alzheimer's | Brain | Chemistry | Clinical Trials | Genetics | Ischemic Stroke | Neurology | Neuroscience | Stroke | USA Health